AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2018
Mar 5, 2018
31676_dirs_2018-03-05_521d7a9e-28cd-4cc9-9e73-b31ae72ae1e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-03-01
Reporting Person: Schrepfer Robert W (SVP - New Bus Dev & Spec Sales)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-01 | Common Stock | M | 18750 | $28.76 | Acquired | 41590 | Direct |
| 2018-03-01 | Common Stock | S | 5498 | $60.33 | Disposed | 36092 | Direct |
| 2018-03-01 | Common Stock | S | 10800 | $61.64 | Disposed | 25292 | Direct |
| 2018-03-01 | Common Stock | S | 11954 | $62.25 | Disposed | 13338 | Direct |
| 2018-03-01 | Common Stock | S | 400 | $63.07 | Disposed | 12938 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-01 | Stock Option | $28.76 | M | 18750 | Disposed | 2024-08-19 | Common Stock (18750) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $61.00 to $61.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $62.00 to $62.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: The options vest and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date of the options was August 20, 2014.